As of 2026-06-09, the Relative Valuation of Innovent Biologics Inc (1801.HK) is 13.42 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 73.25 HKD, the upside of Innovent Biologics Inc based on Relative Valuation is -81.7%.
The range of the Relative Valuation is 11.81 - 16.15 HKD.
| Range | Selected | |
| Trailing P/E multiples | 25.7x - 29.9x | 27.0x |
| Forward P/E multiples | 18.9x - 21.3x | 19.6x |
| Fair Price | 11.81 - 16.15 | 13.42 |
| Upside | -83.9% - -78.0% | -81.7% |
| Date | P/E |
| 2026-06-05 | 1,110.98 |
| 2026-06-04 | 1,108.08 |
| 2026-06-03 | 1,114.61 |
| 2026-06-02 | 1,143.62 |
| 2026-06-01 | 1,173.35 |
| 2026-05-29 | 1,208.88 |
| 2026-05-28 | 1,085.60 |
| 2026-05-27 | 1,145.07 |
| 2026-05-26 | 1,158.12 |
| 2026-05-22 | 1,174.07 |
| 2026-05-21 | 1,197.28 |
| 2026-05-20 | 1,151.59 |
| 2026-05-19 | 1,160.30 |
| 2026-05-18 | 1,164.65 |
| 2026-05-15 | 1,189.30 |
| 2026-05-14 | 1,257.47 |
| 2026-05-13 | 1,262.55 |
| 2026-05-12 | 1,286.48 |
| 2026-05-11 | 1,279.95 |
| 2026-05-08 | 1,305.33 |
| 2026-05-07 | 1,321.29 |
| 2026-05-06 | 1,314.03 |
| 2026-05-05 | 1,334.34 |
| 2026-05-04 | 1,340.87 |
| 2026-04-30 | 1,305.33 |
| 2026-04-29 | 1,231.36 |
| 2026-04-28 | 1,198.00 |
| 2026-04-27 | 1,211.78 |
| 2026-04-24 | 1,244.42 |
| 2026-04-23 | 1,203.81 |
| 2026-04-22 | 1,279.23 |
| 2026-04-21 | 1,303.16 |
| 2026-04-20 | 1,321.29 |
| 2026-04-17 | 1,327.09 |
| 2026-04-16 | 1,340.14 |
| 2026-04-15 | 1,325.64 |
| 2026-04-14 | 1,251.67 |
| 2026-04-13 | 1,260.37 |
| 2026-04-10 | 1,283.58 |
| 2026-04-09 | 1,272.70 |
| 2026-04-08 | 1,295.18 |
| 2026-04-02 | 1,327.09 |
| 2026-04-01 | 1,318.39 |
| 2026-03-31 | 1,231.36 |
| 2026-03-30 | 1,248.77 |
| 2026-03-27 | 1,240.07 |
| 2026-03-26 | 1,151.59 |
| 2026-03-25 | 1,197.28 |
| 2026-03-24 | 1,182.78 |
| 2026-03-23 | 1,124.04 |